劲方医药冲刺港股:年亏损6.78亿 华盖与百度风投是股东

雷递
10 hours ago

雷递网 雷建平 6月28日劲方医药科技(上海)股份有限公司(简称:“劲方医药”)日前更新招股书,准备在港交所上市。年亏损6.78亿劲方医药是一家创新药物开发企业,聚焦肿瘤、免疫类疾病领域高度未满足的临床需求,以疾病生物学机理和临床转化医学为核心,主攻尚无临床验证的创新靶点与适应症。自2017年成立以来,劲方医药已建立包含多个大、小分子项目,多个产品在中国、欧洲、美国进入全球多中心临床试验,包括多项...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10